Plain-English translation of NCT06278285 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to understand how GLP-1 agonist — a medication that helps with weight loss — changes the way your body handles fat and hormones. This study will compare people taking this medication with those who are not, by measuring specific hormone levels in their blood. The goal is to understand the mechanisms behind how this medication works.
After weight-loss surgery, the way fat redistributes in the body can cause health problems. Understanding how this medication affects fat tissue could help doctors prevent these complications and improve long-term outcomes for people undergoing bariatric surgery.
You likely qualify if…
You likely don't qualify if…
You would be divided into two groups: one taking the medication and one not taking it. Your main task would be to donate blood samples so researchers can measure your hormone levels and compare them between the two groups. The study is connected to your weight-loss surgery preparation, and blood draws would likely happen during your regular surgical consultations.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
France
Sponsor
Centre Hospitalier Universitaire de Nice
Enrollment target
~40 participants
Started
March 2024
Primary completion
September 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
ROUX Christian, PhD
Clinique Parc Impérial, Service de Chirurgie Digestive
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.